Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Bacterial Endocarditis HELP
Based on 5,910 articles published since 2009
||||

These are the 5910 published articles about Endocarditis, Bacterial that originated from Worldwide during 2009-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline [Antibiotic prophylaxis in urodynamics: Clinical practice guidelines using a formal consensus method]. 2018

Egrot, C / Dinh, A / Amarenco, G / Bernard, L / Birgand, G / Bruyère, F / Chartier-Kastler, E / Cosson, M / Deffieux, X / Denys, P / Etienne, M / Fatton, B / Fritel, X / Gamé, X / Lawrence, C / Lenormand, L / Lepelletier, D / Lucet, J-C / Marit Ducamp, E / Pulcini, C / Robain, G / Senneville, E / de Sèze, M / Sotto, A / Zahar, J-R / Caron, F / Hermieu, J-F. ·Service d'urologie, université Paris-7, hôpital Bichat Claude-Bernard, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France. Electronic address: christophe.egrot@aphp.fr. · Unité de maladies infectieuses, UVSQ, hôpital Raymond-Poincaré, AP-HP, 92380 Garches, France. · GRC 01, groupe de recherche clinique en neuro-urologie (GREEN), Sorbonne université, hôpital Tenon, AP-HP, 75020 Paris, France. · Service de médecine interne et maladies infectieuses, centre hospitalier régional Bretonneau, 37000 Tours, France. · Centre de prévention des infections associées aux soins, CHU de Nantes, 5, rue du Pr-Boquien, 44000 Nantes, France. · Service d'urologie, centre hospitalier régional universitaire de Tours, 37000 Tours, France. · Médecine Sorbonne Université, hôpital universitaire de la Pitié-Salpêtrière, 75013 Paris, France. · Laboratoire BioTIM, école centrale de Lille, université de Lille, CHU de Lille, 59000 Lille, France. · Service de gynécologie obstétrique, université Paris-Sud, hôpital Antoine-Béclère, groupe hospitalier Sud, AP-HP, 92140 Clamart, France. · Service de neuro-urologie, hôpital Raymond-Poincaré, AP-HP, 92380 Garches, France. · Service de maladies infectieuses et tropicales, hôpital Charles-Nicolle, CHU de Rouen, 76000 Rouen, France. · Unité d'urogynécologie, groupe hospitalier Carémeau, CHU de Nîmes, 30029 Nîmes, France. · Service de gynécologie-obstétrique, CHU de Poitiers, 86000 Poitiers, France. · Département d'urologie, transplantation rénale et andrologie, CHU Rangueil, TSA 50032, 31059 Toulouse, France. · Service microbiologie et hygiène, hôpital Raymond-Poincaré, AP-HP, 92380 Garches, France. · Service d'urologie, centre fédératif de pelvipérinéologie, CHU de Nantes, place A.-Ricordeau, 44093 Nantes cedex 01, France. · Service bactériologie et hygiène hospitalière, CHU de Nantes, 44093 Nantes cedex 01, France. · Service de bactériologie, hygiène, virologie, parasitologie, hôpital Bichat-Claude-Bernard, AP-HP, Paris, France. · Service de médecine physique et réadaptation, urodynamique, clinique Saint-Augustin, 33200 Bordeaux, France. · Infectious Diseases Department, université de Lorraine, APEMAC, CHRU de Nancy, 54000 Nancy, France. · Service de rééducation neurologique, hôpital Rothschild, AP-HP, 75012 Paris, France. · Service universitaire des maladies infectieuses et du voyageur, centre hospitalier Gustave-Dron, CHRU de Lille, 59200 Tourcoing, France. · Service des maladies infectieuses et tropicales, CHU de Nîmes, place du Professeur-Robert-Debré, 30029 Nîmes cedex, France. · Département de microbiologie, hôpital Avicenne, AP-HP, groupe hospitalier Paris-Seine-Saint-Denis, 93000 Bobigny, France; Unité de recherche Inserm 1137, IAME, université Paris-13, 93000 Bobigny, France. · Service des maladies infectieuses, groupe de recherche sur l'adaptation microbienne (EA2656), université de Rouen, CHU de Rouen, 76000 Rouen, France. · Service d'urologie, université Paris-7, hôpital Bichat Claude-Bernard, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France. ·Prog Urol · Pubmed #30501940.

ABSTRACT: OBJECTIVE: The aim of this work was to issue clinical practice guidelines on antibiotic prophylaxis in urodynamics (urodynamic studies, UDS). MATERIALS AND METHODS: Clinical practice guidelines were provided using a formal consensus method. Guidelines proposals were drew up by a multidisciplinary experts group (pilot group = steering group), then rated by a panel of 12 experts (rating group) using a formal consensus method, and then peer reviewed by a reviewing/reading group of experts (different from the rating group). RESULTS: Urine (bacterial) culture with antimicrobial susceptibility testing is recommended for all patients before UDS (strong agreement). In patients with no neurologic disease, the risk factors for tract urinary infection (UTI) after UDS are age > 70 years, recurrent UTI, and post-void residual volume > 100ml. In patients with neurologic disease, the risk factors for UTI after UDS are recurrent UTI, vesicoureteral reflux, and intermicturition pressure > 40cmH CONCLUSION: These new guidelines should help to harmonize clinical practice and limit exposure to antibiotics. LEVEL OF EVIDENCE: 4.

2 Guideline Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). 2018

Chaves, F / Garnacho-Montero, J / Del Pozo, J L / Bouza, E / Capdevila, J A / de Cueto, M / Domínguez, M Á / Esteban, J / Fernández-Hidalgo, N / Fernández Sampedro, M / Fortún, J / Guembe, M / Lorente, L / Paño, J R / Ramírez, P / Salavert, M / Sánchez, M / Vallés, J. ·Servicio de Microbiología, Hospital Universitario 12 de Octubre, Madrid, Spain. · Unidad Clínica de Cuidados Intensivos, Hospital Universitario Virgen Macarena, Sevilla, Spain. Electronic address: jgarnachom@gmail.com. · Área de Enfermedades Infecciosas, Servicio de Microbiología, Clínica Universidad de Navarra, Pamplona, Spain. · Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid; CIBER de Enfermedades Respiratorias, CibeRes, Instituto de Salud Carlos III, Madrid; Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. · Servicio de Medicina Interna, Hospital de Mataró, Mataró, Barcelona, Spain. · Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Sevilla, Spain. · Servicio de Microbiología, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. · Departamento de Microbiología Clínica, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain. · Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Servicio de Enfermedades Infecciosas, Hospital Universitario Marqués de Valdecilla, Santander, Spain. · Unidad de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Unidad de Enfermedades Infecciosas y Microbiología Clínica, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. · Unidad de Cuidados Intensivos, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain. · Unidad de Enfermedades Infecciosas, Hospital Clínico Universitario Lozano Blesa, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain. · Unidad de Cuidados Intensivos, Hospital Universitari i Politècnic La Fe, Valencia; CIBER de Enfermedades Respiratorias (CibeRes), Instituto de Salud Carlos III, Madrid, Spain. · Unidad de Enfermedades Infecciosas, Hospital Universitari i Politècnic La Fe, Valencia, Spain. · Servicio de Medicina Intensiva, Hospital Clínico San Carlos, Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. · Unidad de Cuidados Intensivos, Hospital Universitari Parc Taulí, Sabadell, Barcelona; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain. ·Med Intensiva · Pubmed #29406956.

ABSTRACT: Catheter-related bloodstream infections (CRBSI) constitute an important cause of hospital-acquired infection associated with morbidity, mortality, and cost. The aim of these guidelines is to provide updated recommendations for the diagnosis and management of CRBSI in adults. Prevention of CRBSI is excluded. Experts in the field were designated by the two participating Societies (the Spanish Society of Infectious Diseases and Clinical Microbiology and [SEIMC] and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units [SEMICYUC]). Short-term peripheral venous catheters, non-tunneled and long-term central venous catheters, tunneled catheters and hemodialysis catheters are covered by these guidelines. The panel identified 39 key topics that were formulated in accordance with the PICO format. The strength of the recommendations and quality of the evidence were graded in accordance with ESCMID guidelines. Recommendations are made for the diagnosis of CRBSI with and without catheter removal and of tunnel infection. The document establishes the clinical situations in which a conservative diagnosis of CRBSI (diagnosis without catheter removal) is feasible. Recommendations are also made regarding empirical therapy, pathogen-specific treatment (coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus spp., Gram-negative bacilli, and Candida spp.), antibiotic lock therapy, diagnosis and management of suppurative thrombophlebitis and local complications.

3 Guideline [European society of cardiology guidelines for the management of infective endocarditis (partim 1)]. 2016

Iovino, A / Marchetta, S / Dulgheru, R / Oury, C / Piérard, L A / Lancellotti, P. ·Service de Cardiologie, CHU de Liège, Belgique. · GIGA Cardiovascular Sciences, Heart Valve Clinic. Service de Cardiologie, CHU de Liège, Belgique. · FRS-FNRS, Université de Liège, GIGA-Sciences Cardiovasculaires, Belgique. · Service des Soins Intensifs Cardiologiques, Service de Cardiologie, CHU de Liège, Belgique. ·Rev Med Liege · Pubmed #28383860.

ABSTRACT: Until recently, the recommendations of infective endocarditis were based on expert opinions, due to its low incidence and the absence of controlled trials. The update in 2015 of the new guidelines of the European Society of Cardiology (compared with 2009) relates to the publication of a randomised study on the surgical treatment, the innovations in imaging procedures (especially functional imaging in nuclear medicine) and the new concept of «Team Endocarditis» (multidisciplinary approach). Their aim is to remind the limitations of antibiotic prophylaxis and to insist on hospital hygiene measures. Future challenges will be to obtain a better understanding of the mechanisms associated with the contamination of the valve and to optimize the adaptation of the current epidemiological prophylaxis. In this first part, we will describe the preventive and diagnostic approaches of infective endocarditis.

4 Guideline Guideline on Antibiotic Prophylaxis for Dental Patients at Risk for Infection. 2016

Anonymous11150889. · ·Pediatr Dent · Pubmed #27931473.

ABSTRACT: -- No abstract --

5 Guideline Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association. 2016

Wilson, Walter R / Bower, Thomas C / Creager, Mark A / Amin-Hanjani, Sepideh / O'Gara, Patrick T / Lockhart, Peter B / Darouiche, Rabih O / Ramlawi, Basel / Derdeyn, Colin P / Bolger, Ann F / Levison, Matthew E / Taubert, Kathryn A / Baltimore, Robert S / Baddour, Larry M / Anonymous13220884. · ·Circulation · Pubmed #27737955.

ABSTRACT: -- No abstract --

6 Guideline [Infective endocarditis : New ESC guidelines 2015]. 2016

Plicht, B / Lind, A / Erbel, R. ·Klinik für Kardiologie, Klinikum Westfalen, Am Knappschaftskrankenhaus 1, 44309, Dortmund, Deutschland. bjoern.plicht@klinikum-westfalen.de. · Medizinische Universitätsklinik II, Kardiologie und Angiologie, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum, Deutschland. · Klinik für Kardiologie, Universitätsklinikum Essen, Essen, Deutschland. ·Internist (Berl) · Pubmed #27307162.

ABSTRACT: Infective endocarditis is an endovascular infection usually caused by bacteria. Mortality rate is still approximately 20 %. To improve patients' prognosis by implementation of current diagnostic and therapeutic evidence, the European Society of Cardiology published an updated version of the guidelines for management of infective endocarditis in 2015. It strengthens the role of imaging modalities like PET/CT for detection of infectious foci when echocardiography remains negative and highlights the use of modern tests for identification of possible pathogens. New diagnostic criteria were introduced to integrate these methods for improved diagnostic sensitivity. Complicated cases should be treated in reference centers with on-site cardiac surgery. The antibiotic and early surgical management should be discussed in a multidisciplinary endocarditis team. A few years ago, the indication for endocarditis prophylaxis was limited to high-risk patients. These recommendations were confirmed in current guidelines.

7 Guideline [2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)]. 2016

Habib, Gilbert / Lancellotti, Patrizio / Antunes, Manuel J / Bongiorni, Maria Grazia / Casalta, Jean-Paul / Del Zotti, Francesco / Dulgheru, Raluca / El Khoury, Gebrine / Erba, Paola Anna / Iung, Bernard / Miro, Jose M / Mulder, Barbara J / Plonska-Gosciniak, Edyta / Price, Susanna / Roos-Hesselink, Jolien / Snygg-Martin, Ulrika / Thuny, Franck / Tornos Mas, Pilar / Vilacosta, Isidre / Zamorano, Jose Luis / Anonymous3440865. · ·G Ital Cardiol (Rome) · Pubmed #27093212.

ABSTRACT: -- No abstract --

8 Guideline [2015 ESC Guidelines for the management of infective endocarditis]. 2015

Habib, Gilbert / Lancellotti, Patrizio / Antunes, Manuel J / Bongiorni, Maria Grazia / Casalta, Jean-Paul / Del Zotti, Francesco / Dulgheru, Raluca / El Khoury, Gebrine / Erba, Paola Anna / Iung, Bernard / Miro, Jose M / Mulder, Barbara J / Płońska-Gościniak, Edyta / Price, Sussana / Roos-Hesselink, Jolien / Snygg-Martin, Ulrika / Thuny, Franck / Mas, Pilar Tornos / Vilacosta, Isidre / Zamorano, Jose Luis. ·gilbert.habib2@gmail.com. ·Kardiol Pol · Pubmed #26726820.

ABSTRACT: -- No abstract --

9 Guideline Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association. 2015

Baltimore, Robert S / Gewitz, Michael / Baddour, Larry M / Beerman, Lee B / Jackson, Mary Anne / Lockhart, Peter B / Pahl, Elfriede / Schutze, Gordon E / Shulman, Stanford T / Willoughby, Rodney / Anonymous5840842. · ·Circulation · Pubmed #26373317.

ABSTRACT: -- No abstract --

10 Guideline 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). 2015

Habib, Gilbert / Lancellotti, Patrizio / Antunes, Manuel J / Bongiorni, Maria Grazia / Casalta, Jean-Paul / Del Zotti, Francesco / Dulgheru, Raluca / El Khoury, Gebrine / Erba, Paola Anna / Iung, Bernard / Miro, Jose M / Mulder, Barbara J / Plonska-Gosciniak, Edyta / Price, Susanna / Roos-Hesselink, Jolien / Snygg-Martin, Ulrika / Thuny, Franck / Tornos Mas, Pilar / Vilacosta, Isidre / Zamorano, Jose Luis / Anonymous350841. · ·Eur Heart J · Pubmed #26320109.

ABSTRACT: -- No abstract --

11 Guideline Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). 2015

Gudiol, Francesc / Aguado, José María / Almirante, Benito / Bouza, Emilio / Cercenado, Emilia / Domínguez, M Ángeles / Gasch, Oriol / Lora-Tamayo, Jaime / Miró, José M / Palomar, Mercedes / Pascual, Alvaro / Pericas, Juan M / Pujol, Miquel / Rodríguez-Baño, Jesús / Shaw, Evelyn / Soriano, Alex / Vallés, Jordi. ·Servicio de Enfermedades Infecciosas, IDIBELL, Hospital Universitario de Bellvitge, Barcelona, Spain. · Unidad de Enfermedades Infecciosas, Instituto de Investigación i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: jaguadog1@gmail.com. · Servicio de Enfermedades Infecciosas, Hospital Universitario Valle de Hebrón, Barcelona, Spain. · Servicio de Microbiología y Enfermedades Infecciosas, Hospital Universitario Gregorio Marañón, Madrid, Spain. · Servicio de Microbiología, IDIBELL, Hospital Universitario de Bellvitge, Barcelona, Departamento de patologia y terapeutica experimental, Universidad de Barcelona, Spain. · Servicio de Enfermedades Infecciosas, Hospital Universitari Parc Taulí, Sabadell, Spain. · Unidad de Enfermedades Infecciosas, Instituto de Investigación i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. · Servicio de Enfermedades Infecciosas, Hospital Clinic - IDIBAPS, Universidad de Barcelona, Barcelona, Spain. · Servicio de Medicina Intensiva, Hospital Arnau de Vilanova, Lleida, Spain. · Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Sevilla, Departamento de Microbiología, Universidad de Sevilla, Spain. · Servicio de Enfermedades Infecciosas, Hospital Clinic IDIBAPS, Barcelona, Spain. · Servicio de Cuidados Intensivos, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain. ·Enferm Infecc Microbiol Clin · Pubmed #25937457.

ABSTRACT: Both bacteremia and infective endocarditis caused by Staphylococcus aureus are common and severe diseases. The prognosis may darken not infrequently, especially in the presence of intracardiac devices or methicillin-resistance. Indeed, the optimization of the antimicrobial therapy is a key step in the outcome of these infections. The high rates of treatment failure and the increasing interest in the influence of vancomycin susceptibility in the outcome of infections caused by both methicillin-susceptible and -resistant isolates has led to the research of novel therapeutic schemes. Specifically, the interest raised in recent years on the new antimicrobials with activity against methicillin-resistant staphylococci has been also extended to infections caused by susceptible strains, which still carry the most important burden of infection. Recent clinical and experimental research has focused in the activity of new combinations of antimicrobials, their indication and role still being debatable. Also, the impact of an appropriate empirical antimicrobial treatment has acquired relevance in recent years. Finally, it is noteworthy the impact of the implementation of a systematic bundle of measures for improving the outcome. The aim of this clinical guideline is to provide an ensemble of recommendations in order to improve the treatment and prognosis of bacteremia and infective endocarditis caused by S. aureus, in accordance to the latest evidence published.

12 Guideline Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). 2015

Gudiol, Francesc / Aguado, José María / Almirante, Benito / Bouza, Emilio / Cercenado, Emilia / Domínguez, M Ángeles / Gasch, Oriol / Lora-Tamayo, Jaime / Miró, José M / Palomar, Mercedes / Pascual, Alvaro / Pericas, Juan M / Pujol, Miquel / Rodríguez-Baño, Jesús / Shaw, Evelyn / Soriano, Alex / Vallés, Jordi. ·Servicio de Enfermedades Infecciosas, IDIBELL, Hospital Universitario de Bellvitge, Barcelona, Spain. · Unidad de Enfermedades Infecciosas, Instituto de Investigación i + 12, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: jaguadog1@gmail.com. · Servicio de Enfermedades Infecciosas, Hospital Universitario Valle de Hebrón, Barcelona, Spain. · Servicio de Microbiología y Enfermedades Infecciosas, Hospital Universitario Gregorio Marañón, Madrid, Spain. · Servicio de Microbiología, IDIBELL, Hospital Universitario de Bellvitge, Barcelona, Spain; Departamento de patología y terapéutica experimental, Universidad de Barcelona, Spain. · Servicio de Enfermedades Infecciosas, Hospital Universitari Parc Taulí, Sabadell, Spain. · Unidad de Enfermedades Infecciosas, Instituto de Investigación i + 12, Hospital Universitario 12 de Octubre, Madrid, Spain. · Servicio de Enfermedades Infecciosas, Hospital Clínic - IDIBAPS, Universidad de Barcelona, Barcelona, Spain. · Servicio de Medicina Intensiva, Hospital Arnau de Vilanova, Lleida, Spain. · Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Sevilla, Spain; Departamento de Microbiología, Universidad de Sevilla, Spain. · Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Sevilla, Spain; Departamento de Medicina, Universidad de Sevilla, Spain. · Servicio de Cuidados Intensivos, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain. ·Enferm Infecc Microbiol Clin · Pubmed #25937456.

ABSTRACT: Bacteremia and infective endocarditis caused by Staphylococcus aureus are common and severe diseases. Optimization of treatment is fundamental in the prognosis of these infections. The high rates of treatment failure and the increasing interest in the influence of vancomycin susceptibility in the outcome of infections caused by both methicillin-susceptible and -resistant isolates have led to research on novel therapeutic schemes. The interest in the new antimicrobials with activity against methicillin-resistant staphylococci has been extended to susceptible strains, which still carry the most important burden of infection. New combinations of antimicrobials have been investigated in experimental and clinical studies, but their role is still being debated. Also, the appropriateness of the initial empirical therapy has acquired relevance in recent years. The aim of this guideline is to update the 2009 guidelines and to provide an ensemble of recommendations in order to improve the treatment of staphylococcal bacteremia and infective endocarditis, in accordance with the latest published evidence.

13 Guideline [Clinical guidelines for the prevention of infective endocarditis]. 2014

Pérez-Lescure Picarzo, J / Crespo Marcos, D / Centeno Malfaz, F / Anonymous100755. ·Área de Pediatría y Neonatología, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España. Electronic address: fjplescure@fhalcorcon.es. · Área de Pediatría y Neonatología, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España. · Servicio de Pediatría, Hospital Universitario Río Hortega, Valladolid, España. ·An Pediatr (Barc) · Pubmed #23562531.

ABSTRACT: This article sets out the recommendations for the prevention of infective endocarditis (IE), contained in the guidelines developed by the American Heart Association (AHA) and the European Society of Cardiology (ESC), from which the recommendations of the Spanish Society of Paediatric Cardiology and Congenital Heart Disease have been agreed. In recent years, there has been a considerable change in the recommendations for the prevention of IE, mainly due to the lack of evidence on the effectiveness of antibiotic prophylaxis in prevention, and the risk of the development of antibiotic resistance. The main change is a reduction of the indications for antibiotic prophylaxis, both in terms of patients and procedures considered at risk. Clinical practice guidelines and recommendations should assist health professionals in making clinical decisions in their daily practice. However, the ultimate judgment regarding the care of a particular patient must be taken by the physician responsible.

14 Guideline Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. 2012

Gould, F Kate / Denning, David W / Elliott, Tom S J / Foweraker, Juliet / Perry, John D / Prendergast, Bernard D / Sandoe, Jonathan A T / Spry, Michael J / Watkin, Richard W / Working Party of the British Society for Antimicrobial Chemotherapy, ?. ·Department of Microbiology, Freeman Hospital, Newcastle upon Tyne, UK. kate.gould@nuth.nhs.uk ·J Antimicrob Chemother · Pubmed #22086858.

ABSTRACT: The BSAC guidelines on treatment of infectious endocarditis (IE) were last published in 2004. The guidelines presented here have been updated and extended to reflect developments in diagnostics, new trial data and the availability of new antibiotics. The aim of these guidelines, which cover both native valve and prosthetic valve endocarditis, is to standardize the initial investigation and treatment of IE. An extensive review of the literature using a number of different search criteria has been carried out and cited publications used to support any changes we have made to the existing guidelines. Publications referring to in vitro or animal models have only been cited if appropriate clinical data are not available. Randomized, controlled trials suitable for the development of evidenced-based guidelines in this area are still lacking and therefore a consensus approach has again been adopted for most recommendations; however, we have attempted to grade the evidence, where possible. The guidelines have also been extended by the inclusion of sections on clinical diagnosis, echocardiography and surgery.

15 Guideline ACOG Practice Bulletin No. 120: Use of prophylactic antibiotics in labor and delivery. 2011

Anonymous3990695. · ·Obstet Gynecol · Pubmed #21606770.

ABSTRACT: -- No abstract --

16 Guideline Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. 2011

Feltes, Timothy F / Bacha, Emile / Beekman, Robert H / Cheatham, John P / Feinstein, Jeffrey A / Gomes, Antoinette S / Hijazi, Ziyad M / Ing, Frank F / de Moor, Michael / Morrow, W Robert / Mullins, Charles E / Taubert, Kathryn A / Zahn, Evan M / Anonymous2500693 / Anonymous2510693 / Anonymous2520693 / Anonymous2530693. · ·Circulation · Pubmed #21536996.

ABSTRACT: -- No abstract --

17 Guideline Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. 2011

Liu, Catherine / Bayer, Arnold / Cosgrove, Sara E / Daum, Robert S / Fridkin, Scott K / Gorwitz, Rachel J / Kaplan, Sheldon L / Karchmer, Adolf W / Levine, Donald P / Murray, Barbara E / J Rybak, Michael / Talan, David A / Chambers, Henry F. ·Department of Medicine, Division of Infectious Diseases, University of California-San Francisco, San Francisco, California 94102, USA. catherine.liu@ucsf.edu ·Clin Infect Dis · Pubmed #21217178.

ABSTRACT: Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.

18 Guideline Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. 2011

Liu, Catherine / Bayer, Arnold / Cosgrove, Sara E / Daum, Robert S / Fridkin, Scott K / Gorwitz, Rachel J / Kaplan, Sheldon L / Karchmer, Adolf W / Levine, Donald P / Murray, Barbara E / J Rybak, Michael / Talan, David A / Chambers, Henry F / Anonymous770683. ·Department of Medicine, Division of Infectious Diseases, University of California-San Francisco, San Francisco, California94102, USA. catherine.liu@ucsf.edu ·Clin Infect Dis · Pubmed #21208910.

ABSTRACT: Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.

19 Guideline [Indications for cardiology consultation and management of cardiac patients who will undergo surgical or endoscopic procedures: the proposal of the University Hospital of Trieste, Italy]. 2010

Massa, Laura / Vitrella, Giancarlo / Zecchin, Massimo / Berlot, Giorgio / Bergamini, Pier Riccardo / Pelusi, Lucia / Lattuada, Luca / Sinagra, Gianfranco / Anonymous11370677. ·S.C. di Cardiologia, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Trieste. ·G Ital Cardiol (Rome) · Pubmed #21033337.

ABSTRACT: The number of patients affected by cardiovascular disease admitted to internal medicine and geriatric wards is expanding due to the increasing prevalence of cardiovascular disease in the ageing population. This contributes to a growing demand for cardiology consult visits, with requests for perioperative risk stratification for non-cardiac surgery or endoscopy, and general clinical management. This document was jointly drafted by the Cardiology and Anesthesiology departments, medical and surgical departments, and endoscopy services of the Azienda Ospedaliero-Universitaria "Ospedali Riuniti" in Trieste (Italy). It addresses critical issues such as antiplatelet and anticoagulant therapy in non-cardiac surgery, electric device management, and prophylaxis of bacterial endocarditis. It provides general guidelines and appropriateness criteria, prompted by the Joint Commission International and approved by the Hospital Guidelines Committee. It provides a basis for periodic educational meetings, and will be periodically updated. Periodic audits will monitor its application, and critical and controversial points, in order to promote quality of health care, organizational efficiency, and appropriateness.

20 Guideline [Antibiotic prophylaxis in gastrointestinal endoscopy--recommendations of the Austrian Society of Gastroenterology and Hepatology]. 2010

Wewalka, F / Kapral, C / Brownstone, E / Homoncik, M / Renner, F / Anonymous5810673. ·Interne Abteilung 4, Krankenhaus der Elisabethinen Linz, Linz. friedrich.wewalka@elisabethinen.or.at ·Z Gastroenterol · Pubmed #20886429.

ABSTRACT: The recommendations of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) for antibiotic prophylaxis in gastrointestinal endoscopy of the year 2002 have been updated in accord with the recently published guidelines of the American Society of Gastrointestinal Endoscopy (ASGE) and the American Heart Association (AHA). Antibiotic prophylaxis for any endoscopic intervention to prevent infectious endocarditis is no longer necessary. Moreover, the prophylactic use of antibiotics for ERCP without biliary obstruction and ERCP with obstruction and a likelihood of complete drainage is no longer recommended. For ERCP with obstruction and anticipated incomplete drainage, a full course of antibiotics should be administered to prevent cholangitis. For the prevention of local infections antibiotics are useful prior to endoscopic puncturing, contrasting or drainage of cystic lesions as well as just before application of a PEG tube. In cirrhotic patients with GI bleeding antibiotic prophylaxis should be started as early as possible and be administered for several days.

21 Guideline Antibiotic prophylaxis in gastrointestinal endoscopy. 2009

Allison, M C / Sandoe, J A T / Tighe, R / Simpson, I A / Hall, R J / Elliott, T S J / Anonymous4210628. ·Gastroenterology Unit, Royal Gwent Hospital, Newport NP20 2UB, UK. milesallison@newport11.fsnet.co.uk ·Gut · Pubmed #19433598.

ABSTRACT: -- No abstract --

22 Guideline [Evaluation of the status of patients with severe infection, criteria for intensive care unit admittance. Spanish Society for Infectious Diseases and Clinical Microbiology. Spanish Society of Intensive and Critical Medicine and Coronary Units]. 2009

Olaechea, Pedro M / Alvarez-Lerma, Francisco / Sánchez, Miguel / Torres, Antonio / Palomar, Mercedes / Fernández, Pedro / Miró, José M / Cisneros, José Miguel / Torres, Manuel / Anonymous6920627 / Anonymous6930627. ·Medicina Intensiva, Hospital de Galdakao, Vizcaya, España. pedromaria.olaecheaastigarrag@osakideta.net ·Enferm Infecc Microbiol Clin · Pubmed #19409668.

ABSTRACT: Recent studies have shown that early attention in patients with serious infections is associated with a better outcome. Assistance in intensive care units (ICU) can effectively provide this attention; hence patients should be admitted to the ICU as soon as possible, before clinical deterioration becomes irreversible. The objective of this article is to compile the recommendations for evaluating disease severity in patients with infections and describe the criteria for ICU admission, updating the criteria published 10 years ago. A literature review was carried out, compiling the opinions of experts from the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC, Spanish Society for Infectious Diseases and Clinical Microbiology) and the Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC, Spanish Society for Intensive Medicine, Critical Care and Coronary Units) as well as the working groups for infections in critically ill patients (GEIPC-SEIMC and GTEI-SEMICYUC). We describe the specific recommendations for ICU admission related to the most common infections affecting patients, who will potentially benefit from critical care. Assessment of the severity of the patient's condition to enable early intensive care is stressed.

23 Guideline [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]. 2009

Gudiol, Francisco / Aguado, José María / Pascual, Alvaro / Pujol, Miquel / Almirante, Benito / Miró, José María / Cercenado, Emilia / Domínguez, María de Los Angeles / Soriano, Alex / Rodríguez-Baño, Jesús / Vallés, Jordi / Palomar, Mercedes / Tornos, Pilar / Bouza, Emilio / Anonymous1000623. ·Servicio de Enfermedades Infecciosas, IDIBELL, Hospital Universitario de Bellvitge, Barcelona, España. ·Enferm Infecc Microbiol Clin · Pubmed #19254641.

ABSTRACT: Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA) are prevalent and clinically important. The rise in MRSA bacteremia and endocarditis is related with the increasing use of venous catheters and other vascular procedures. Glycopeptides have been the reference drugs for treating these infections. Unfortunately their activity is not completely satisfactory, particularly against MRSA strains with MICs > 1 microg/mL. The development of new antibiotics, such as linezolid and daptomycin, and the promise of future compounds (dalvabancin, ceftobiprole and telavancin) may change the expectatives in this field.The principal aim of this consensus document was to formulate several recommendations to improve the outcome of MRSA bacteremia and endocarditis, based on the latest reported scientific evidence. This document specifically analyzes the approach for three clinical situations: venous catheter-related bacteremia, persistent bacteremia, and infective endocarditis due to MRSA.

24 Guideline Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. 2009

Gerber, Michael A / Baltimore, Robert S / Eaton, Charles B / Gewitz, Michael / Rowley, Anne H / Shulman, Stanford T / Taubert, Kathryn A. · ·Circulation · Pubmed #19246689.

ABSTRACT: Primary prevention of acute rheumatic fever is accomplished by proper identification and adequate antibiotic treatment of group A beta-hemolytic streptococcal (GAS) tonsillopharyngitis. Diagnosis of GAS pharyngitis is best accomplished by combining clinical judgment with diagnostic test results, the criterion standard of which is the throat culture. Penicillin (either oral penicillin V or injectable benzathine penicillin) is the treatment of choice, because it is cost-effective, has a narrow spectrum of activity, and has long-standing proven efficacy, and GAS resistant to penicillin have not been documented. For penicillin-allergic individuals, acceptable alternatives include a narrow-spectrum oral cephalosporin, oral clindamycin, or various oral macrolides or azalides. The individual who has had an attack of rheumatic fever is at very high risk of developing recurrences after subsequent GAS pharyngitis and needs continuous antimicrobial prophylaxis to prevent such recurrences (secondary prevention). The recommended duration of prophylaxis depends on the number of previous attacks, the time elapsed since the last attack, the risk of exposure to GAS infections, the age of the patient, and the presence or absence of cardiac involvement. Penicillin is again the agent of choice for secondary prophylaxis, but sulfadiazine or a macrolide or azalide are acceptable alternatives in penicillin-allergic individuals. This report updates the 1995 statement by the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee. It includes new recommendations for the diagnosis and treatment of GAS pharyngitis, as well as for the secondary prevention of rheumatic fever, and classifies the strength of the recommendations and level of evidence supporting them.

25 Editorial ["That most interesting disease"]. 2019

Delahaye, François. ·Université Claude Bernard Lyon I, hospices civils de Lyon, 69677 Bron cedex, France. Electronic address: francois.delahaye@chu-lyon.fr. ·Presse Med · Pubmed #31160016.

ABSTRACT: -- No abstract --

Next